Evidence-based practices in geriatric mental health care:: an overview of systematic reviews and meta-analyses

被引:41
作者
Bartels, SJ
Dums, AR
Oxman, TE
Schneider, LS
Areán, PA
ALexopoulos, GS
Jeste, DV
机构
[1] Dartmouth Coll Sch Med, Dept Psychiat, Lebanon, NH 03756 USA
[2] New Hampshire Dartmouth Psychiat Res Ctr, Lebanon, NH 03755 USA
[3] Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA
[4] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
[5] Weill Cornell Med Coll, Dept Psychiat, White Plains, NY 10605 USA
[6] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92161 USA
[7] San Diego Vet Affairs Med Ctr, San Diego, CA 92161 USA
关键词
D O I
10.1016/S0193-953X(03)00072-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
At least 20% of people over the age of 65 suffer from mental disorders. It is anticipated that the number of older Americans with psychiatric disorders will double over the next 30 years. There is, however, substantial unmet need. The recent Surgeon General's Report on Mental Health a Report on Mental Health from the Administration on Aging, and an expert consensus statement underscore the need to plan for the challenge of providing services for elderly people with major mental disorders. Among the greatest challenges is the expertise gap that affects clinicians practicing in routine clinical settings. This gap reflects inadequate training in geriatrics and a failure to incorporate contemporary clinical research findings and known evidence-based practices (EBPs) into usual care. This article provides an overview of the emerging evidence-base supporting the efficacy of empirically-validated geriatric mental health interventions for major geriatric mental health disorders, including systematic EBP reviews, meta-analytic studies, and expert consensus statements. Cautions and limitations regarding the reliance on randomized, controlled trials, meta-analyses, and systematic reviews also are presented.
引用
收藏
页码:971 / +
页数:22
相关论文
共 101 条
[61]   Efficacy and safety of neuroleptics in behavioral disorders associated with dementia [J].
Lanctot, KL ;
Best, TS ;
Mittmann, N ;
Liu, BA ;
Oh, PI ;
Einarson, TR ;
Naranjo, CA .
JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (10) :550-561
[62]   Diagnosis and treatment of depression in late life - Consensus statement update [J].
Lebowitz, BD ;
Pearson, JL ;
Schneider, LS ;
Reynolds, CF ;
Alexopoulos, GS ;
Bruce, ML ;
Conwell, Y ;
Katz, IR ;
Meyers, BS ;
Morrison, MF ;
Mossey, J ;
Niederehe, G ;
Parmelee, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (14) :1186-1190
[63]   Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: Effects on social adjustment [J].
Lenze, EJ ;
Dew, MA ;
Mazumdar, S ;
Begley, AE ;
Cornes, C ;
Miller, MD ;
Imber, SD ;
Frank, E ;
Kupfer, DJ ;
Reynolds, CF .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (03) :466-468
[64]   Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials [J].
Leucht, S ;
Pitschel-Walz, G ;
Abraham, D ;
Kissling, W .
SCHIZOPHRENIA RESEARCH, 1999, 35 (01) :51-68
[65]  
LIMA MS, 2002, DRUGS VERSUS PLACEBO
[66]   Conflict-of-interest policies for investigators in clinical trials. [J].
Lo, B ;
Wolf, LE ;
Berkeley, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1616-1620
[67]  
LONERGAN E, 2002, HALOPERIDOL AGITATIO
[68]   Depression in Alzheimer's disease: Overview and treatment [J].
Lyketsos, CG ;
Olin, J .
BIOLOGICAL PSYCHIATRY, 2002, 52 (03) :243-252
[69]  
Maixner SM, 1999, J CLIN PSYCHIAT, V60, P29
[70]   Drug therapy - Treatment of Alzheimer's disease [J].
Mayeux, R ;
Sano, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (22) :1670-1679